Cann Group Ltd (CAN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cann Group Ltd (CAN) has a cash flow conversion efficiency ratio of 0.000x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-11.00K ≈ $-7.78K USD) by net assets (AU$34.16 Million ≈ $24.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Cann Group Ltd market capitalisation for the company's overall valuation and market capitalisation.
Cann Group Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Cann Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cann Group Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cann Group Ltd ranked by their cash flow conversion efficiency. Explore CAN cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RKEC Projects Limited
NSE:RKEC
|
0.014x |
|
Gibb River Diamonds Ltd
AU:GIB
|
-1.410x |
|
Foresight Solar Fund Ltd
LSE:FSFL
|
0.015x |
|
MPC Energy Solutions NV
OL:MPCES
|
0.002x |
|
Stellar AfricaGold Inc.
V:SPX
|
-0.152x |
|
THREED CAPITAL INC.
F:B5K3
|
N/A |
|
Genesis Resources Ltd
AU:GES
|
-0.764x |
|
CASA DE BUCOVINA-CLUB DE MUNTE
RO:BCM
|
-0.009x |
Annual Cash Flow Conversion Efficiency for Cann Group Ltd (2015–2025)
The table below shows the annual cash flow conversion efficiency of Cann Group Ltd from 2015 to 2025. View Cann Group Ltd share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$-2.77 Million ≈ $-1.96 Million |
AU$-9.64 Million ≈ $-6.82 Million |
3.475x | +418.57% |
| 2024-06-30 | AU$13.92 Million ≈ $9.85 Million |
AU$-15.19 Million ≈ $-10.74 Million |
-1.091x | -183.08% |
| 2023-06-30 | AU$59.26 Million ≈ $41.93 Million |
AU$-22.84 Million ≈ $-16.16 Million |
-0.385x | -60.11% |
| 2022-06-30 | AU$84.90 Million ≈ $60.07 Million |
AU$-20.43 Million ≈ $-14.46 Million |
-0.241x | -6.15% |
| 2021-06-30 | AU$91.87 Million ≈ $65.01 Million |
AU$-20.83 Million ≈ $-14.74 Million |
-0.227x | +21.40% |
| 2020-06-30 | AU$61.07 Million ≈ $43.21 Million |
AU$-17.62 Million ≈ $-12.47 Million |
-0.288x | -200.42% |
| 2019-06-30 | AU$77.30 Million ≈ $54.69 Million |
AU$-7.42 Million ≈ $-5.25 Million |
-0.096x | -119.63% |
| 2018-06-30 | AU$85.87 Million ≈ $60.76 Million |
AU$-3.75 Million ≈ $-2.66 Million |
-0.044x | +72.12% |
| 2017-06-30 | AU$14.66 Million ≈ $10.37 Million |
AU$-2.30 Million ≈ $-1.63 Million |
-0.157x | +78.75% |
| 2016-06-30 | AU$1.69 Million ≈ $1.20 Million |
AU$-1.25 Million ≈ $-882.14K |
-0.738x | +25.57% |
| 2015-06-30 | AU$648.33K ≈ $458.73K |
AU$-642.74K ≈ $-454.78K |
-0.991x | -- |
About Cann Group Ltd
Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.